During pathological cardiac hypertrophy, the heart develops insulin resistance, resulting in a slower rate of glucose entry in response to insulin and a decrease in the capacity for glucose oxidation [20,21], without changes in the expression of GLUT4 transporters [22]. This evidence concerns the gene INS and cardiac hypertrophy.